Newer oral contraceptives pose higher VTE risk

The risk of developing venous thromboembolism is generally greater for women using oral contraceptives with newer types of progestogen hormones than for those taking older, second-generation birth...

Field of Interest: Pulmonology
Type: News Item

Outcomes worse for lung cancer patients with VTE

Hospitalized lung cancer patients who had venous thromboembolisms had significantly worse outcomes than did other patients, according to a study publi... More »

Field of Interest: Oncology
Type: News Item

Apixiban for VTE reduced subsequent hospitalizations

WASHINGTON – Treating acute venous thromboembolism with the fixed-dose oral factor Xa inhibitor apixaban significantly reduces subsequent all-cause hospitalizations, compared with conventional...

Field of Interest: Cardiology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.